Address |
Cambridge Discovery Park Cambridge Massachusetts 02140 United States |
Employees | - |
Website | http://www.genocea.com |
Updated | 07/08/2019 |
Genocea Biosciences engages in the development and commercialization of cancer vaccines. It uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-003, an investigational immunotherapy for the treatment of genital herpes; and GEN-009, a neoantigen cancer vaccine. |